Gitelman Syndrome

Gitelman Syndrome is a rare inherited condition that affects the kidneys, specifically the way they handle salt and minerals. It primarily involves the tubules, which are tiny structures in the kidneys responsible for filtering and balancing electrolytes like potassium, magnesium, and calcium. People with this condition often have low levels of potassium and magnesium in their blood, which can cause symptoms like muscle cramps, weakness, and fatigue. The syndrome affects the body's ability to maintain proper fluid and electrolyte balance, which is important for normal muscle and nerve function. Although it can cause discomfort, it usually does not lead to severe kidney damage. The condition is lifelong and requires monitoring of electrolyte levels to manage symptoms.

Gitelman Syndrome is an autosomal recessive renal tubular disorder caused by mutations in the SLC12A3 gene encoding the thiazide-sensitive sodium-chloride cotransporter (NCC) in the distal convoluted tubule. This defect leads to impaired reabsorption of sodium and chloride, resulting in hypokalemia, hypomagnesemia, and hypocalciuria. The syndrome is characterized by chronic renal salt wasting, secondary hyperaldosteronism, and metabolic alkalosis. It typically presents in late childhood or adulthood with symptoms related to electrolyte imbalances such as muscle weakness, cramps, and fatigue. Unlike Bartter syndrome, Gitelman syndrome features low urinary calcium excretion. The disorder is clinically significant due to its impact on electrolyte homeostasis and potential for causing cardiac arrhythmias if untreated.